Article info
PDFHealth services research
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention Of Pelvic Infection (POPI) trial
- Correspondence to Adamma Aghaizu, St George's, University of London, London SW17 0RE, UK; aaghaizu{at}sgul.ac.uk
Citation
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention Of Pelvic Infection (POPI) trial
Publication history
- Accepted February 21, 2011
- First published March 28, 2011.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.